Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy

Eisai

Status: Completed

Conditions: Epilepsy

Treatments: Drug: Fycompa

Study type: Observational

Funder types: Industry

Identifiers

NCT03208660

E2007-G000-506

Details and patient eligibility

About

This study is conducted to assess the retention rate of Fycompa when given in routine clinical care.

Enrollment: 2,000 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Participants must have met all of the following criteria to be included in this study:

  1. Diagnosis of epilepsy
  2. Initiated treatment with Fycompa at any time after 01 Jan 2014
  3. Provided written informed consent by the participant or the participant's legally authorized representative signed for the use of medical records (if required by an Institutional Review Board [IRB] or Independent Ethics Committee [IEC], or by regulatory authorities).

Exclusion criteria

• Not applicable

Trial design

2,000 participants in 1 patient group

Fycompa

Description:

Participants diagnosed with epilepsy and treated with Fycompa

Treatment:

Drug: Fycompa